brain aneurysm: A congenital or acquired aneurysm within the cranium.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
332 |
4. Check minimum number of eventsNone |
332 |
5. Include endpointsNone |
332 |
6. Filter based on genotype QC (FinnGen only) |
332 |
Control definitions (FinnGen only)
- Control exclude
- I9_CEREBVASC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I67
- Name in latin
- Thrombosis non pyogenes systematis venosi intracranialis
Similar endpoints
↥List of similar endpoints to
Nonpyogenic thrombosis of intracranial venous system
based on the number of shared cases.
Similar with more cases:
- Cerebrovascular diseases (FINNGEN)
- Cerebrovascular diseases
- Neurological diseases, wide definition
- Cardiovascular diseases (excluding rheumatic etc)
- Cardiovascular diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1945 | 1146 | 787 |
| Only index persons | 1787 | 1081 | 706 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.04 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 47.77 | 44.15 | 53.10 |
| Only index persons | 47.16 | 43.52 | 52.73 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 332 | 218 | 114 |
| Unadjusted period prevalence (%) | 0.07 | 0.07 | 0.05 |
| Median age at first event (years) | 48.97 | 44.93 | 56.70 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 302
- Matched controls
- 3018
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
+∞
323.0
301
*
B01AA03
ATC
warfarin; systemic
24.4
119.4
194
207
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
16.6
65.8
113
105
AA1AD
NOMESCO Finland
CT of head and brain
7.6
47.8
135
291
R51.80
ICD-10 Finland
Headache
7.2
43.9
127
277
B01AB05
ATC
enoxaparin; parenteral
5.6
40.4
158
495
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
442.0
40.1
39
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
21.7
38.5
57
32
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
334.1
30.4
30
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
39.3
28.1
35
10
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.4
25.8
74
146
XA800
NOMESCO Finland
Neuropsychological investigation
12.4
24.6
45
42
N03AX14
ATC
levetiracetam; systemic
16.3
21.8
35
24
K91
ICPC
Cerebrovascular disease
224.9
20.8
21
*
I63.6
ICD-10 Finland
Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
+∞
20.0
19
*
K90
ICPC
Stroke/cerebrovascular accident
59.1
19.2
22
*
XF400
NOMESCO Finland
ECG with 12 standard connections
4.4
19.0
77
219
K94
ICPC
Phlebitis/thrombophlebitis
19.1
18.6
28
16
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
7.8
17.9
42
61
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
+∞
17.9
17
*
H47.1
ICD-10 Finland
Papilloedema, unspecified
67.3
16.9
19
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
+∞
16.8
16
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.3
16.1
51
111
K99
ICPC
Cardiovascular disease other
11.3
15.1
28
27
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
19.6
14.9
22
12
G44.2
ICD-10 Finland
Tension-type headache
3.9
14.8
67
207
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
15.2
14.8
24
17
WX892
NOMESCO Finland
Monitored bed care
5.4
14.7
45
94
B01AB04
ATC
dalteparin; parenteral
7.9
14.5
33
46
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.4
14.0
37
64
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
15.7
13.8
22
15
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.5
13.7
69
233
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
+∞
13.6
13
*
R4110
NOMESCO Finland
Physiotherapy
2.9
13.5
98
425
N03AF02
ATC
oxcarbazepine; oral
9.6
12.5
25
28
PA2AD
NOMESCO Finland
CT angiography of brain
39.3
12.3
15
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
13.2
12.3
21
17
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
12.1
83
345
A02BC02
ATC
pantoprazole; systemic
2.4
11.7
201
1373
R4120
NOMESCO Finland
Occupational therapy
5.2
11.6
36
76
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
17.9
11.3
17
10
R42
ICD-10 Finland
Dizziness and giddiness
3.0
11.1
72
287
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.2
11.0
42
111
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
10.2
10.9
21
22
AA1BD
NOMESCO Finland
Extensive CT of head and brain
10.2
10.9
21
22
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
22.4
10.8
15
7
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
+∞
10.5
10
*
I67.7
ICD-10 Finland
Cerebral arteritis, not elsewhere classified
+∞
10.5
10
*
G93.2
ICD-10 Finland
Benign intracranial hypertension
+∞
10.5
10
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
+∞
10.5
10
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
10.5
53
178
R4150
NOMESCO Finland
Neuropsychological rehabilitation
27.0
9.9
13
5
D68.8
ICD-10 Finland
Other specified coagulation defects
15.7
9.6
15
10
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
9.5
132
784
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
+∞
9.4
9
*
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
+∞
9.4
9
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
10.5
9.1
17
17
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.8
9.1
25
46
B01AB10
ATC
tinzaparin; parenteral
4.9
9.1
29
64
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
5.3
8.7
26
53
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
8.6
8.7
18
22
N02BE01
ATC
paracetamol; systemic, rectal
2.6
8.6
260
2138
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
+∞
8.4
8
*
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
+∞
8.4
8
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.1
8.4
32
85
H02AB06
ATC
prednisolone; systemic
2.1
8.3
145
934
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
8.2
38
119
TAB00
NOMESCO Finland
Lumbar puncture
4.7
8.2
27
62
N03AB02
ATC
phenytoin; systemic
17.8
8.1
12
7
K78
ICPC
Atrial fibrillation/flutter
4.4
8.0
28
68
C10AA05
ATC
atorvastatin; oral
2.2
7.9
97
536
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.8
7.8
25
56
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.4
7.7
22
43
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
8.4
7.7
16
20
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
7.5
93
517
S01EC01
ATC
acetazolamide; systemic
8.7
7.4
15
18
G41.0
ICD-10 Finland
Grand mal status epilepticus
+∞
7.3
7
*
WX882
NOMESCO Finland
High dependency care
6.3
7.2
18
30
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
12.4
7.1
12
10
XCK00
NOMESCO Finland
Perimetry
4.1
7.1
26
67
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
14.2
6.9
11
8
R41.0
ICD-10 Finland
Disorientation, unspecified
9.6
6.9
13
14
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
17.2
6.8
10
6
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
41.0
6.8
8
*
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.7
6.7
28
81
N03AG01
ATC
valproic acid; systemic, rectal
3.7
6.7
28
81
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
71.3
6.4
7
*
A04AA02
ATC
granisetron; systemic, transdermal
4.0
6.3
24
64
WX002
NOMESCO Finland
Sedation and analgesia
2.3
6.3
59
285
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
+∞
6.3
6
*
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
+∞
6.3
6
*
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
7.9
6.2
13
17
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.7
6.2
25
71
N03AX18
ATC
lacosamide; systemic
12.9
6.1
10
8
WX872
NOMESCO Finland
Intensive care
4.8
6.1
19
42
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
6.1
34
121
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4306422)
92
30
42.04
145.57
1.2
1.2
—
—
—
0
0
(3036489) Thrombin time
109
89
17.74
116.38
4.1
2.7
s
20.6
22.1
1.49
80
76
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
79
35
29.31
111.90
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
71
31
28.86
100.77
1.4
1.1
u/ml
2.8
3.3
0.21
37
13
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
67
30
27.73
94.00
1.4
1.1
u/ml
3.3
1.4
0.65
18
12
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
79
54
18.89
91.83
4.9
3.8
u/ml
0.5
0.3
4.26
65
31
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
82
72
14.80
82.54
5.2
3.2
%
185.4
178.6
0.24
82
72
(4268621)
52
21
29.17
75.29
2.3
2.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
34
12
31.45
51.00
1.4
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
174
664
4.41
39.76
3.0
2.0
u/l
138.9
315.7
1.05
166
626
(3033658) Prothrombin time (PT) actual/Normal
165
613
4.36
38.96
6.7
3.8
%
93.9
93.1
0.13
159
600
(3032080) INR in Blood by Coagulation assay
203
876
4.39
38.90
19.6
7.4
inr
1.6
1.2
4.11
62
284
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
30
17
19.30
37.25
1.2
1.1
ratio
1.0
1.1
—
7
6
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
150
594
3.78
30.89
3.9
1.8
mg/l
2.3
1.2
0.92
114
442
(3022217) INR in Platelet poor plasma by Coagulation assay
86
254
4.22
26.53
36.4
17.8
inr
1.7
1.3
—
10
39
(3012095) Magnesium [Moles/volume] in Serum or Plasma
105
382
3.56
23.69
5.5
4.5
mmol/l
0.8
0.8
0.00
99
360
(3044290) Cell count panel - Cerebral spinal fluid
33
47
7.69
22.47
1.7
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
242
1475
3.36
22.16
8.4
5.1
mmol/l
6.6
6.5
0.10
234
1350
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
21
20
11.14
19.30
1.4
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
207
1220
2.85
18.87
12.4
7.1
mmol/l
1.2
1.2
0.29
184
1033
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
18
15
12.63
17.94
2.4
1.9
umol/l
11.8
12.0
0.03
18
15
(3011412) CD3 cells [#/volume] in Blood
22
27
8.66
16.83
2.4
2.1
e9/l
1.2
1.2
0.04
12
12
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
21
7
31.88
16.31
1.1
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
19
20
10.02
16.26
2.5
2.2
%
7.3
10.7
—
10
15
(3023368) Bacteria identified in Blood by Culture
124
598
2.71
16.21
5.5
4.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
186
1097
2.58
15.99
12.4
6.5
mmol/l
1.2
1.2
1.37
173
999
(3003458) Phosphate [Moles/volume] in Serum or Plasma
77
292
3.13
15.63
9.6
7.4
mmol/l
1.1
1.1
0.27
72
273
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
30
57
5.69
15.44
1.7
1.2
e6/l
12.8
2.5
0.65
21
45
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
30
57
5.69
15.44
1.8
1.3
e6/l
9304.4
138.1
0.48
21
46
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
20
9.46
14.79
3.1
2.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
19
8
25.08
13.94
1.1
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
170
1013
2.39
13.60
8.7
5.3
g/l
35.0
36.1
1.72
164
938
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
204
1324
2.40
13.32
9.5
6.4
umol/l
11.0
11.9
0.48
196
1255
(3022096) Basophils/100 leukocytes in Blood
193
1228
2.37
13.11
11.6
5.6
%
0.7
0.7
0.11
188
1145
(42870588) Differential panel, method unspecified - Blood
150
857
2.37
13.08
12.8
5.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
202
1314
2.37
12.99
11.6
5.7
%
28.1
29.0
0.57
195
1234
(3006504) Eosinophils/100 leukocytes in Blood
196
1270
2.33
12.56
11.6
5.6
%
2.6
2.7
0.53
191
1186
(3036481) Cortisol [Moles/volume] in Serum or Plasma
65
253
2.95
12.43
3.1
2.0
nmol/l
363.0
359.2
0.05
60
231
(3018010) Neutrophils/100 leukocytes in Blood
199
1302
2.32
12.41
11.0
5.5
%
57.1
56.5
0.24
193
1227
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
83
370
2.66
12.27
2.5
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
116
607
2.40
12.19
2.4
2.0
mg/l
3.8
3.0
1.07
97
523
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
94
448
2.53
12.10
5.6
3.7
ng/l
94.0
355.9
1.69
62
317
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
17
23
7.74
11.95
1.9
2.1
e9/l
0.1
0.2
0.17
12
16
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
65
262
2.84
11.62
2.3
1.8
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
17
24
7.41
11.52
1.8
2.1
e6/l
422.5
484.3
0.25
12
17
(3001604) Monocytes [#/volume] in Blood
202
1363
2.23
11.25
10.9
5.5
e9/l
0.6
0.6
0.68
178
1194
(3019198) Lymphocytes [#/volume] in Blood
207
1411
2.24
11.24
10.8
5.5
e9/l
1.9
1.9
0.01
183
1260
(3006315) Basophils [#/volume] in Blood
202
1371
2.21
10.98
10.9
5.5
e9/l
0.0
0.0
0.65
180
1201
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
64
265
2.75
10.84
2.4
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
16
23
7.26
10.67
2.2
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
15
20
7.81
10.64
1.5
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
70
308
2.61
10.50
3.6
2.5
%
21.4
23.9
0.72
59
269
(3003396) Base excess in Arterial blood by calculation
58
234
2.79
10.30
12.4
11.4
mmol/l
1.0
1.4
0.38
46
190
(3018418) pH of Serum or Plasma
129
751
2.17
10.18
5.9
3.3
ph
7.4
7.4
1.22
23
135
(3013650) Neutrophils [#/volume] in Blood by Automated count
219
1579
2.14
9.63
16.5
8.9
e9/l
4.2
4.0
0.74
198
1387
(3026782) Osmolality of Urine
95
499
2.27
9.57
4.4
2.6
mosm/kgh2o
579.5
562.9
0.28
82
423
(3013115) Eosinophils [#/volume] in Blood
202
1416
2.09
9.54
12.3
5.9
e9/l
0.2
0.2
0.16
179
1259
(3002582) Erythrocytes [#/volume] in Urine
129
768
2.11
9.47
4.7
3.2
e6/l
44.7
43.1
0.03
97
583
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
17
30
5.92
9.37
1.0
1.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
33
101
3.52
9.31
13.1
14.3
mmol/l
24.4
24.6
0.14
33
93
(3013707) Erythrocyte sedimentation rate by Westergren method
259
2008
2.32
9.30
5.2
3.8
mm/h
12.7
10.1
2.00
242
1849
(36304419) Bacteria [Presence] in Urine
120
702
2.11
9.17
4.5
3.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
131
795
2.07
9.05
3.6
2.5
u/l
52.4
55.5
0.75
126
738
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
12
9.45
9.02
1.3
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
119
702
2.08
8.83
4.7
3.1
e6/l
0.3
0.3
0.03
88
518
(3027945) Reticulocytes/100 erythrocytes in Blood
57
248
2.57
8.67
4.6
3.3
%
1.8
1.8
0.02
49
226
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
78
393
2.29
8.59
3.5
3.1
e6/l
3.4
2.6
0.23
42
213
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
146
940
1.99
8.41
2.1
1.9
pmol/l
98.1
94.7
0.35
86
480
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
68
3.89
8.34
3.1
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
41
154
2.90
8.26
14.2
9.2
mmol/l
24.0
25.0
1.28
41
154
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
142
910
1.98
8.25
4.6
3.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
241
1855
2.09
8.22
5.5
4.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
164
1106
1.95
8.20
3.0
2.4
nmol/l
75.8
75.6
0.03
144
998
(3010503) CD19 cells [#/volume] in Blood
10
11
9.34
8.12
3.1
1.8
e9/l
0.1
0.1
—
10
11
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
34
116
3.15
8.08
14.4
16.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
74
375
2.25
8.00
1.3
1.4
titre
342.2
528.6
—
9
84
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
24
6.05
7.92
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
24
6.05
7.92
1.2
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
177
1235
1.93
7.90
3.7
2.8
ug/l
94.4
100.7
0.19
164
1158
(3044640) Blood type and Crossmatch panel - Blood
128
815
1.93
7.41
3.6
2.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
50
220
2.50
7.39
6.9
4.8
mmol/l
1.6
1.9
0.27
44
173
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
78
417
2.14
7.33
3.1
2.9
e6/l
0.8
0.9
0.11
41
237
(3042936) Bacteria identified in Isolate by Culture
71
366
2.20
7.32
2.1
2.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
252
2011
2.05
7.24
12.6
7.0
u/l
82.4
78.0
0.51
245
1882
(3018095) Leukocytes [#/volume] in Urine
139
917
1.89
7.17
5.0
3.7
e6/l
125.5
82.7
0.27
99
632
(3019309) Folate [Moles/volume] in Red Blood Cells
76
407
2.12
7.10
1.5
1.6
nmol/l
1053.3
1227.2
0.92
54
307
(3028026) IgM [Mass/volume] in Serum or Plasma
41
168
2.64
7.00
2.4
1.6
g/l
0.9
1.9
1.44
36
151
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
115
2.97
6.96
1.9
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
20
6.19
6.95
1.2
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
136
900
1.87
6.88
4.7
3.2
u/l
32.0
31.2
0.08
130
856
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
173
1243
1.82
6.63
5.3
4.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
9
12.59
6.63
1.6
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
59
296
2.21
6.46
2.5
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
32
121
2.82
6.36
2.7
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
116
748
1.85
6.25
2.8
2.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
34
135
2.69
6.17
1.3
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
130
871
1.81
6.17
5.0
3.3
mmol/l
2.3
2.4
0.98
109
774
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
311
2758
3.02
6.13
26.5
12.0
mg/l
20.7
21.3
0.13
269
2107
(3021960) Folate [Moles/volume] in Serum or Plasma
91
550
1.90
5.97
1.6
1.5
nmol/l
18.7
21.0
0.95
84
476
(3000991) Gas panel - Venous blood
42
189
2.40
5.90
16.2
10.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
58
300
2.13
5.87
2.9
3.5
umol/l
9.0
8.6
0.03
52
258
(21494434) Karyotype in Bone marrow
11
20
5.65
5.84
1.2
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
171
1256
1.75
5.82
15.9
8.7
e9/l
0.0
0.0
0.27
137
1020
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
32
4.52
5.82
1.3
2.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
130
884
1.77
5.79
3.7
3.2
ng/l
16.7
36.0
2.88
75
534
(40758558) Short blood count panel - Blood
105
670
1.83
5.78
11.4
6.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
82
3.08
5.70
2.4
2.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
37
162
2.44
5.52
1.8
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
86
524
1.87
5.45
4.1
2.5
e6/l
11.5
6.7
0.57
75
462
(3019550) Sodium [Moles/volume] in Serum or Plasma
310
2775
2.77
5.41
28.7
13.3
mmol/l
139.5
139.7
0.81
305
2696
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
24
85
2.97
5.37
1.9
2.2
ug/l
1.3
4.2
0.44
16
80
(3002179) Metamyelocytes/100 leukocytes in Blood
41
191
2.31
5.33
6.9
4.8
%
0.9
0.4
—
10
42
(3021901) Oxygen saturation in Capillary blood
15
39
3.98
5.32
3.3
2.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
95
603
1.81
5.26
3.7
2.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
43
206
2.25
5.24
6.8
4.8
%
1.4
0.9
0.48
13
63
(3023103) Potassium [Moles/volume] in Serum or Plasma
310
2783
2.72
5.22
29.2
13.4
mmol/l
3.9
4.0
1.91
303
2696
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
27
4.57
5.08
1.6
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
99
643
1.77
5.05
4.3
2.5
umol/l
3408.9
7742.1
0.59
84
569
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
19
63
3.14
4.75
1.5
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
11
8.37
4.59
1.3
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
34
3.94
4.58
2.8
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
23
88
2.73
4.50
10.8
5.3
kpa
9.5
8.9
0.85
23
80
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
21
77
2.84
4.44
1.9
1.5
iu/ml
0.0
0.1
—
6
13
(40767503) Oxygen content in Capillary blood by calculation
14
40
3.61
4.38
3.6
2.5
%
16.9
16.7
—
7
19
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
10
22
4.66
4.33
1.4
2.1
e6/l
380.2
483.9
—
5
8
(3045142) Bone marrow Pathology biopsy report
10
22
4.66
4.33
1.5
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
22
4.66
4.33
1.6
2.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
34
162
2.22
4.21
9.5
5.4
mmol/l
1.6
1.5
0.05
20
127
(3035637) Corticotropin [Mass/volume] in Plasma
12
32
3.85
4.12
1.5
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
10
8.16
4.08
1.3
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
40
207
2.06
4.03
2.2
2.1
e9/l
3.7
3.9
0.33
30
169
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
42
222
2.02
4.00
6.0
4.1
ug/l
6.0
39.7
0.52
37
173
(3028192) IgG subclass 2 [Mass/volume] in Serum
12
33
3.74
3.96
1.2
1.3
g/l
3.8
2.8
—
7
26
(4062490)
12
33
3.74
3.96
1.3
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
24
101
2.48
3.91
1.0
1.3
—
4.4
—
0
6
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
225
1885
1.60
3.85
4.0
3.1
u/l
40.2
44.2
0.55
217
1780
(3021440) Promyelocytes/100 leukocytes in Blood
37
190
2.07
3.81
7.5
5.1
%
0.2
0.1
0.07
11
55
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
55
3.01
3.79
1.5
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
55
3.01
3.79
1.5
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
34
170
2.11
3.75
9.8
5.3
kpa
5.0
5.2
0.69
34
156
(3009343) pH of Capillary blood
34
171
2.10
3.70
9.6
5.2
ph
7.4
7.4
—
5
16
(3008037) Lactate [Moles/volume] in Venous blood
14
45
3.20
3.69
3.3
2.6
mmol/l
1.3
1.3
0.11
14
45
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
8
12
6.80
3.69
1.3
2.8
%
233.8
119.0
—
8
12
(3025159) Blasts/100 leukocytes in Blood
36
186
2.05
3.65
7.2
5.1
%
0.1
0.2
—
10
48
(3023520) Reticulocytes [#/volume] in Blood
35
180
2.06
3.59
5.5
3.5
e9/l
77.7
73.3
0.26
26
138
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
17
5.41
3.53
5.2
2.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
13
6.27
3.52
1.0
1.0
—
—
—
0
0
(44790049)
12
36
3.42
3.51
2.3
1.7
—
—
—
0
0
(44806118)
12
36
3.42
3.51
2.3
1.7
—
—
—
0
0
(44790048)
12
36
3.42
3.51
2.2
1.7
—
—
—
0
0
(44790047)
12
36
3.42
3.51
2.2
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
30
147
2.14
3.49
2.8
2.4
u/l
11252.3
2179.0
0.73
13
53
(3007164) IgA [Mass/volume] in Serum or Plasma
87
601
1.61
3.38
1.9
1.4
g/l
2.0
2.3
1.24
66
361
(3052851) Hemolysis interference index of Serum or Plasma
18
71
2.62
3.35
3.9
3.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
22
96
2.38
3.34
1.8
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
44
253
1.85
3.29
3.7
3.2
—
—
—
0
0
(3019225) pH of Specimen
37
201
1.95
3.28
6.9
4.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
66
2.66
3.27
2.9
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
14
49
2.94
3.23
2.9
2.0
g/l
129.2
132.5
—
9
33
(40765096) Chromosome analysis panel by Banding
7
11
6.47
3.20
1.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
34
3.31
3.08
2.9
1.3
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
5
5
10.12
2.99
2.2
3.4
umol/l
38.0
52.0
—
5
5
(3017143) Hepatitis C virus Ab [Presence] in Serum
55
349
1.69
2.96
2.0
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
283
2567
1.69
2.95
4.3
3.6
mmol/l
1.4
1.3
2.44
261
2384
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
13
5.48
2.88
1.4
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
13
5.48
2.88
1.4
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
74
513
1.57
2.80
1.4
1.7
pmol/l
474.6
443.3
0.36
61
443
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
23
3.99
2.79
8.3
4.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
48
2.78
2.75
2.4
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
161
1312
1.44
2.74
4.0
3.4
estimate
0.0
0.0
0.00
40
262
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
312
2926
2.10
2.73
17.2
9.3
u/l
27.0
25.9
0.52
304
2836
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
10
6.09
2.71
1.0
1.0
%
126.2
140.0
—
6
10
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
31
170
1.91
2.69
1.4
2.3
ug/l
6.7
8.4
0.23
25
150
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
67
2.46
2.67
3.0
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
27
143
1.97
2.59
10.4
7.7
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
13
50
2.67
2.56
9.1
3.3
kpa
9.1
9.1
0.02
13
50
(3013290) Carbon dioxide [Partial pressure] in Blood
13
50
2.67
2.56
9.1
3.3
kpa
5.0
5.0
0.08
13
50
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
33
3.09
2.55
1.1
1.3
nmol/l
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
160
1318
1.41
2.49
5.4
4.7
estimate
0.0
0.0
0.50
40
265
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
279
2550
1.59
2.48
5.6
4.6
mu/l
1.7
1.8
1.89
261
2357
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
240
2128
1.46
2.46
4.8
4.0
pmol/l
14.7
14.6
0.33
224
1952
(3025941) Bacteria identified in Stool by Culture
29
161
1.88
2.44
1.2
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
161
1332
1.41
2.43
4.0
3.4
estimate
0.0
0.0
0.00
39
252
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
20
97
2.13
2.42
2.4
1.5
g/l
1.2
1.2
0.24
20
92
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
39
238
1.72
2.42
3.8
2.4
u/l
29.8
30.4
0.05
32
199
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
27
3.40
2.41
1.1
2.2
ug/l
30.1
29.1
—
9
27
(3022806) Fractional oxyhemoglobin in Capillary blood
9
27
3.40
2.41
2.6
2.4
%
90.7
89.7
—
9
27
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
8
6.32
2.38
1.8
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
62
429
1.55
2.35
4.7
2.8
mmol/l
2.4
2.4
0.29
53
366
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
18
85
2.18
2.33
1.9
1.9
—
—
—
0
0
(4035726)
37
226
1.72
2.30
1.6
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
47
2.61
2.29
3.2
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
19
93
2.11
2.26
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
82
607
1.47
2.26
2.4
3.1
ng/l
1625.8
859.1
0.72
67
504
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
30
173
1.81
2.26
5.0
4.6
ng/l
68.4
71.5
0.10
24
157
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
9
29
3.16
2.24
1.2
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
23
122
1.95
2.22
4.2
3.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
67
2.30
2.21
2.2
2.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
309
2917
1.86
2.20
22.9
11.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
19
3.74
2.16
1.1
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
12
49
2.50
2.13
1.4
1.4
g/l
0.4
0.7
—
7
40
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
25
3.25
2.11
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
25
3.25
2.11
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
25
3.25
2.11
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
88
669
1.43
2.10
6.7
4.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
100
778
1.41
2.10
4.4
3.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
12
50
2.45
2.05
8.3
3.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
287
2669
1.56
2.04
4.9
4.1
mmol/l
4.6
4.7
0.67
267
2498
(3038515) Glucose [Moles/volume] in Venous blood
11
44
2.55
2.03
3.6
2.7
mmol/l
6.6
7.0
0.42
11
44
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
69
504
1.47
2.03
2.0
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
89
682
1.42
2.03
1.9
1.7
mmol/l
1.5
1.4
0.53
84
588
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
26
3.13
2.02
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
26
3.13
2.02
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
26
3.13
2.02
1.1
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
16
3.80
1.94
1.2
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
10
39
2.61
1.94
10.9
5.0
%
70.3
65.2
—
10
39
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
34
2.69
1.88
1.2
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
64
469
1.45
1.85
1.2
1.3
u/ml
10.9
8.2
0.13
22
182
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
17
3.57
1.84
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
17
3.57
1.84
1.2
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
80
2.05
1.83
2.2
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
263
2419
1.42
1.83
6.0
5.1
mmol/mol
39.1
38.9
0.07
244
2276
(3004616) Nuclear Ab [Presence] in Serum
9
35
2.61
1.81
1.4
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
23
3.09
1.81
1.0
5.3
%
99.4
95.7
—
7
23
(3021879) Hepatitis B virus core Ab [Presence] in Serum
33
210
1.63
1.79
1.5
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
14
67
2.14
1.78
1.1
1.3
—
57.1
—
0
7
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
284
2656
1.48
1.74
4.9
4.0
mmol/l
1.4
1.5
1.66
261
2479
(3041354) Potassium [Moles/volume] in Venous blood
8
30
2.71
1.73
2.4
2.7
mmol/l
4.0
3.9
—
8
30
(3035285) Chloride [Moles/volume] in Venous blood
8
30
2.71
1.73
2.4
2.7
mmol/l
107.4
105.6
—
8
30
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
65
484
1.43
1.73
1.3
1.3
iu/ml
17.1
26.5
1.08
17
152
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
13
3.89
1.72
2.8
1.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
13
3.89
1.72
1.4
7.8
u/ml
—
36.4
—
0
5
(3029075) Extractable nuclear Ab panel - Serum
5
13
3.89
1.72
1.0
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
202
1793
1.32
1.70
4.0
3.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
42
2.42
1.69
1.8
1.5
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
6
19
3.20
1.67
1.8
1.5
umol/l
10.3
20.2
—
6
19
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
33
215
1.59
1.64
2.8
2.3
—
15.3
—
0
11
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
14
3.61
1.62
2.8
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
14
3.61
1.62
1.2
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
5
14
3.61
1.62
1.2
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
77
1.99
1.62
1.5
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
22
129
1.76
1.61
2.5
1.8
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
20
114
1.80
1.60
6.5
3.5
%
1.5
1.3
0.25
20
114
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
288
2712
1.47
1.58
5.4
4.4
mmol/l
2.8
2.8
0.56
268
2526
(46235355) HIV 1 and 2 tests - Meaningful Use set
80
627
1.36
1.58
2.3
2.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
64
2.07
1.56
4.4
4.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
22
131
1.73
1.53
11.8
5.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
277
2595
1.41
1.52
4.6
4.1
mmol/l
5.9
5.8
0.09
249
2388
(3051611) Lipemic interference index of Serum or Plasma
6
21
2.89
1.51
6.8
4.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
37
2.47
1.49
1.1
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
52
2.15
1.46
8.5
6.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
59
2.07
1.45
1.2
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
16
3.16
1.44
2.2
2.9
u/ml
395.6
675.3
—
5
16
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
81
1.89
1.42
1.1
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
40
2.28
1.41
2.8
3.5
—
—
—
0
0
(3013512) EKG study
85
684
1.33
1.40
4.6
3.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
42
301
1.45
1.38
1.9
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
270
2530
1.36
1.38
21.7
10.6
ml/min/173m2
86.9
86.4
0.14
242
2039
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
41
2.23
1.38
1.1
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
23
2.64
1.37
13.7
7.4
%
10.2
11.6
—
6
23
(3012441) Differential panel - Pleural fluid
5
17
2.97
1.36
1.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
114
1.71
1.31
2.1
1.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
24
2.53
1.31
1.0
1.1
—
77.6
—
0
5
(40761536) Microorganisms panel - Urine sediment
34
237
1.48
1.29
6.3
3.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
277
2614
1.36
1.28
29.8
13.0
%
39.6
40.1
0.54
200
2027
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
35
2.32
1.27
2.6
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
28
188
1.53
1.26
2.4
3.6
pmol/l
4.2
4.6
1.06
22
165
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
64
1.91
1.19
1.9
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
72
580
1.31
1.18
2.6
3.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
39
2.08
1.16
1.0
1.1
—
—
—
0
0
(44813793)
5
20
2.52
1.15
1.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
20
2.52
1.15
3.6
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
94
787
1.27
1.15
1.6
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
45
339
1.38
1.14
1.1
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
30
2.36
1.13
2.6
2.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
31
2.28
1.11
4.3
2.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
36
263
1.41
1.09
1.5
1.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
21
2.40
1.09
1.6
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
37
272
1.41
1.09
1.5
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
7
33
2.14
1.06
7.3
4.1
%
0.7
1.5
—
7
26
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
33
2.14
1.06
3.0
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
11
190
0.56
1.06
1.5
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
79
654
1.27
1.05
3.5
3.1
mg/l
961.1
161.7
0.42
53
419
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
29
205
1.45
1.05
1.4
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
90
758
1.26
1.04
4.3
3.1
mmol/l
8.0
7.6
0.39
78
642
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
81
676
1.26
1.01
1.3
1.3
u/ml
0.8
0.9
0.13
26
175
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
9
49
1.86
0.99
7.9
3.0
u/ml
41.8
34.3
—
9
49
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
23
2.19
0.98
1.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
23
2.19
0.98
1.4
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
54
1.88
0.97
2.2
1.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
82
689
1.25
0.97
5.0
3.9
mg/mmol
9.5
8.8
0.05
53
429
(1002224) Polysomnography panel
20
133
1.54
0.97
1.2
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
119
1044
1.22
0.94
4.4
3.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
27
2.24
0.94
1.2
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
27
2.24
0.94
6.3
3.1
u/ml
25.3
43.8
—
6
27
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
206
0.62
0.92
1.6
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
28
2.16
0.92
1.2
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
42
1.93
0.89
15.4
3.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
43
1.88
0.88
2.9
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
196
1.41
0.87
5.1
2.5
ml/min/173m2
79.8
70.4
1.14
18
71
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
44
1.84
0.86
1.5
1.4
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
6
31
1.95
0.85
1.2
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
89
1.60
0.82
1.4
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
139
1.47
0.81
2.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
20
139
1.47
0.81
2.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
20
139
1.47
0.81
2.0
1.4
—
—
—
0
0
(4094501)
10
58
1.75
0.80
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
25
336
0.72
0.80
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
20
140
1.46
0.79
2.0
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.2
—
1.9
—
0
8
(3049717) Cytology report of Urine Cyto stain
12
75
1.62
0.76
2.4
2.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
19
133
1.45
0.75
2.1
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
121
1085
1.18
0.74
2.4
1.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
2.6
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
56
1.62
0.73
3.3
2.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
39
1.81
0.73
1.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
40
1.77
0.71
1.9
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
40
1.77
0.71
1.9
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
28
362
0.75
0.71
1.6
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
41
1.72
0.70
1.9
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
41
1.72
0.70
1.9
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
41
1.72
0.70
1.9
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
41
1.72
0.70
1.9
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
317
3105
1.46
0.70
38.6
17.7
e9/l
270.0
253.7
3.46
310
3041
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
27
1.86
0.68
1.2
1.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
317
3109
1.43
0.64
38.5
17.6
e12/l
4.5
4.5
1.46
310
3038
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
41
335
1.26
0.64
1.7
1.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
317
3110
1.43
0.63
38.6
17.7
e9/l
7.0
6.6
2.82
309
3038
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
50
1.61
0.61
1.3
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
30
1.68
0.61
1.4
2.0
pg
34.2
33.1
—
5
30
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
11.1
—
0.6
—
0
22
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
64
1.58
0.59
1.4
1.4
—
—
—
0
0
(4281824)
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
38
312
1.25
0.57
1.2
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
37
1.63
0.56
1.7
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
124
0.64
0.55
1.4
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
66
1.53
0.53
2.7
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
40
1.51
0.52
3.3
2.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
45
1.57
0.49
5.1
3.2
e9/l
3.0
4.6
—
7
45
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
57
498
1.17
0.48
4.7
4.1
%
21.2
22.4
0.18
24
219
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
47
1.50
0.48
8.3
3.7
%
53.7
56.9
—
7
47
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
85
1.43
0.47
1.3
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
78
700
1.15
0.47
4.6
3.6
estimate
0.0
0.0
0.50
38
259
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
117
0.68
0.46
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
117
0.68
0.46
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
118
0.67
0.46
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
118
0.67
0.46
1.3
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
164
0.72
0.46
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
84
0.59
0.46
2.0
1.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
51
1.38
0.44
1.3
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
104
1.36
0.44
2.6
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
56
1.44
0.43
1.8
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
70
1.44
0.42
2.3
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
2.0
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.9
—
0
8
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
61
544
1.15
0.40
1.3
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
60
1.34
0.40
1.6
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
101
0.69
0.40
1.4
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
105
0.66
0.40
2.0
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
13
98
1.34
0.38
2.1
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
112
0.71
0.38
1.5
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
69
1.31
0.37
1.7
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
33
282
1.19
0.37
4.6
3.9
%
29.5
31.9
0.54
22
185
(3019832) Treponema pallidum Ab [Presence] in Serum
43
377
1.16
0.36
1.7
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
15
117
1.30
0.36
2.0
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
42
1.44
0.35
1.0
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
51
569
0.88
0.34
3.8
3.5
kg/l
1.0
1.0
—
6
74
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
11
142
0.77
0.31
1.3
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
98
0.71
0.31
1.3
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
99
0.70
0.31
1.3
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
7
56
1.26
0.29
1.6
1.0
—
1.7
—
0
10
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
208
2013
1.09
0.29
3.6
3.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
57
1.23
0.29
2.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
205
0.82
0.29
1.2
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
12
94
1.29
0.28
5.9
4.6
g/l
0.1
0.3
—
7
36
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
122
1.24
0.27
2.4
2.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
68
629
1.10
0.26
4.8
4.5
ug/l
1.8
2.4
0.45
61
559
(40761535) Cells panel - Urine sediment
22
190
1.17
0.23
2.1
3.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
168
0.83
0.23
1.1
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
39
1.29
0.23
2.8
1.7
—
—
—
0
0
(4211845)
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
19.5
—
0
12
(3017704) Immunofixation for Urine
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
43
1.17
0.21
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
61
652
0.92
0.20
2.1
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
52
1.16
0.19
1.5
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
40
368
1.10
0.18
3.4
2.8
ug/l
0.8
0.7
0.08
31
229
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
25
226
1.11
0.15
1.5
1.2
iu/ml
136.2
181.7
—
5
90
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
121
1.16
0.15
1.1
1.5
—
—
—
0
0
(3020891) Body temperature
10
84
1.20
0.14
6.3
3.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
106
1.14
0.10
1.1
1.2
—
—
—
0
0
(3000492) Spirometry study
24
257
0.93
0.09
1.8
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
105
1075
0.97
0.08
2.8
2.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
6
58
1.04
0.08
3.2
2.7
ug/min
24.5
56.1
—
6
35
(36660697) Celiac disease serology panel - Serum
26
248
1.05
0.05
1.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
15
160
0.93
0.04
3.0
2.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
11
101
1.09
0.04
3.4
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
28
289
0.97
0.02
1.3
1.7
—
—
—
0
0
(4010399)
19
182
1.05
0.02
1.5
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
188
0.96
0.02
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
28
286
0.98
0.00
6.4
6.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
46
458
1.01
0.00
2.1
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
41
415
0.99
0.00
2.0
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
154
0.97
0.00
1.1
1.1
—
—
—
0
0
(4034850)
8
86
0.93
0.00
31.6
6.7
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
69
0.87
0.00
1.7
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
52
0.96
0.00
1.6
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
1.3
—
0
6
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
8
0.00
0.00
0.0
3.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
95
0.95
0.00
1.1
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
2.2
—
0
5
(40765089) Chromosome analysis panel - Blood by G-banded
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.4
—
4.8
—
0
8
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
97
0.93
0.00
1.1
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
94
0.96
0.00
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
98
0.92
0.00
1.8
1.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.8
—
0
5
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
9
0.00
0.00
0.0
7.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
2.6
—
4.4
—
0
5
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_THROMBICV and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_THROMBICV | 2.151 [1.58, 2.92] | < 0.001 |
| Birth year | 0.994 [0.98, 1.0] | 0.19 |
During the follow-up period (1.1.1998 — 31.12.2019), 100 out of 916 females with I9_THROMBICV died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_THROMBICV | 2.538 [1.86, 3.46] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 119 out of 619 males with I9_THROMBICV died.
Mortality risk
Mortality risk for people of age
years, who have I9_THROMBICV.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.224% | 0.476% |
| 5 | 1.437% | 3.118% |
| 10 | 3.209% | 7.444% |
| 15 | 5.841% | 13.79% |
| 20 | 10.125% | 22.083% |
Relationships between endpoints
↥Index endpoint: I9_THROMBICV – Nonpyogenic thrombosis of intracranial venous system
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data